VARCT Diagnostics is a MedTech company developing novel in-vitro cancer diagnostics based on the detection of oncofetal Chondroitin Sulfate, a tumor-specific glycosaminoglycan discovered by our founders in 2012 present in most cancers and in circulating tumor biomarkers.
This company has no teams yet
This company has no offices yet